Holzer Holzer & Fistel, LLC is investigating potential violations of the federal securities laws by Mindray Medical International Limited (“Mindray” or the “Company”) (NYSE: MR). The investigation focuses on whether a series of statements made between January 11, 2010 and August 9, 2010, inclusive, regarding Mindray’s business, its prospects and its operations were materially false and misleading at the time they were made.

Specifically, the investigation focuses on, among other things, whether the Company knew but failed to adequately disclose that it was experiencing declining sales domestically. The investigation also seeks to determine whether Mindray understated the level of competition it faced in penetrating the market for larger hospital systems in China.

If you invested in Mindray American depository shares (“ADSs”) between January 11, 2010 and August 9, 2010, inclusive and have questions concerning your legal rights, you are encouraged to contact Holzer Holzer & Fistel, LLC and its attorneys Michael I. Fistel Jr., Esq. or Marshall P. Dees, Esq. via email at mfistel@holzerlaw.com, or mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832.

Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.

Copyright Business Wire 2010